Covestor Ltd - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Covestor Ltd ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6
-25.0%
192
-0.5%
0.01%
-16.7%
Q2 2023$8
+14.3%
193
-0.5%
0.01%0.0%
Q1 2023$7
-50.0%
194
-48.7%
0.01%0.0%
Q4 2022$14
-99.9%
378
+100.0%
0.01%
-40.0%
Q3 2022$11,000
+10.0%
189
-0.5%
0.01%
+25.0%
Q2 2022$10,000
+66.7%
190
+131.7%
0.01%
+100.0%
Q1 2022$6,0000.0%82
+78.3%
0.00%
-50.0%
Q4 2021$6,000460.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders